Market Tracker

04/20 5:15pm ET

Melinta Therapeutics, Inc. (NASDAQ:MLNT)

7.45
Delayed Data
As of Apr 20
 0.00 / 0.00%
Today’s Change
6.50
Today|||52-Week Range
24.25
-52.85%
Year-to-Date
No recent news for Melinta Therapeutics, Inc..

Today’s Trading

Previous close7.45
Today’s open7.35
Day’s range7.15 - 7.63
Volume120,831
Average volume (3 months)164,038
Market cap$421.3M
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)-11.96%
Earnings growth (this year)+58.89%
Earnings growth (next 5 years)--
Revenue growth (last year)-34.03%
P/E ratioNM
Price/Sales7.82
Price/Book0.77

Competitors

 Today’s
change
Today’s
% change
SMMTSummit Therapeutics ...+0.13+0.95%
VRNAVerona Pharma PLC-0.19-1.13%
NTECIntec Pharma Ltd+0.10+1.90%
ACRXAcelRx Pharmaceutica...-0.07-3.09%
Data as of 4:00pm ET, 04/20/2018

Financials

Next reporting dateApril 27, 2018
EPS forecast (this quarter)-$4.20
Annual revenue (last year)$18.0M
Annual profit (last year)-$118.0M
Net profit margin-654.76%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Daniel Mark Wechsler
CFO, Secretary &
Principal Accounting Officer
Paul Estrem
Corporate headquarters
New Haven, Connecticut

Forecasts